Centricity™ PACS Workstation - Software

Performance

Date

2025-07-03

Country

Canada

Classification

Type II

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2025-07-04
2. CA
   Drugs & medicalType I

   PMS-Methylphenidate CR 10 mg capsule; exceed the acceptable intake limit for N-nitroso-methylphenidate

   Product quality

   Health CanadaOfficial notice →
3. CA
   Drugs & medicalType II

   CONTOUR® NEXT GEN Blood Glucose Monitoring System

   Performance

   Health CanadaOfficial notice →
4. CA
   Drugs & medicalType II

   INNOVANCE® VWF Ac assay

   Performance

   Health CanadaOfficial notice →
5. 2025-07-03
6. CA
   Drugs & medicalType I

   RIVA-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetine

   Product quality

   Health CanadaOfficial notice →
7. CA
   Drugs & medicalType II

   ASPIRE Cristalle Mammography System

   Unauthorised device

   Health CanadaOfficial notice →
8. 2025-07-02
9. CA
   Drugs & medicalType II

   B-Sight SCLERAL

   Performance

   Health CanadaOfficial notice →